Trial Profile
A study to evaluate the feasibility of a treatment algorithm in newly diagnosed asthmatic children. An open follow-up to Asthma Prevention in Infants/Young Children (PAC)
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 22 Jan 2008
Price :
$35
*
At a glance
- Drugs Budesonide (Primary)
- Indications Asthma
- Focus Therapeutic Use
- Sponsors AstraZeneca
- 11 Jan 2008 Status changed from in progress to completed as reported by ClinicalTrials.gov.
- 30 Mar 2006 New trial record.